The Group Room at the 2012 American Society of Clinical Oncology Annual Meeting
The Group Room produced many interviews on a variety of topics. Dr. Clifford Hudis gives an overview of some exciting breast cancer data. Dr. Michael Atkins and Dr. Patrick Hwu bring us exciting news and information in melanoma, Dr. Heinz-Josef Lenz talks to us about cancer of the “GE” junction, Dr. David Quinn talks bladder and other GU cancer advances, Dr. Otis Brawley talks to us about the PSA test, and we attend a poster session with Dr. Daniel Von Hoff and so many more!
Michael B. Atkins, MD: New Therapies and New Questions for Metastatic Melanoma
Dr. Atkins (Georgetown Lombardi Cancer Center) discusses how the approval of several new drugs to treat patients with malignant melanoma is creating tremendous excitement, but also lots of new questions.
Otis Webb Brawley, MD: Prostate Cancer and PSA Screeing. To Test or Not To Test? and African-Americans and Sun Screen. Yes! You Need it.
Dr. Brawley (American Cancer Society) sits down with The Group Room and talks PSA testing and the importance of shielding from the sun for all skin types!
Paul A. Bunn, Jr., MD: Lung Cancer Update ASCO 2012
Dr. Bunn (University of Colorado) discusses clinical updates in lung cancer as well as upcoming events for the International Association for the Study of Lung Cancer (IASLC).
Lynette Denny, MD, PhD: ASCO 2012 Gynecological Cancer Update – A Global Perspective and Gynecologic Cancer Care in South Africa
Dr. Denny discusses gynecologic cancer updates from her perspective as an oncologist from Cape Town, South Africa and gives us a look into cancer care in her region of the world.
Clifford A. Hudis, MD: T-DM1 EMILIA Trial for HER-2 Positive Advanced Breast Cancer, Paclitaxel Beats Out Newer Agents in the Treatment of Advanced Breast Cancer, Tissue Collection and Clinical Trials in Breast Cancer Research and Patient Health Records and Advancing Technology
Dr. Hudis (Memorial Sloan-Kettering) discusses breast cancer updates, tissue collection and health records.
Patrick Hwu, MD: Melanoma Research & Treatment Update From ASCO 2012 and Why Is Melanoma So Difficult To Treat?
Dr. Hwu (MD Anderson Cancer Center) gives a melanoma research and treatment update as well as a discussion on why melanoma is so difficult to treat.
Gretchen Kimmick, MD, MS: Cardiovascular Complications Related to Cancer Treatment
Dr. Kimmick (Duke University) discusses long and short-term cardiovascular complications related to cancer treatment.
Heinz-Josef Lenz, MD: Colorectal Cancer Highlights ASCO 2012, The CMET Pathway for Gastric (Stomach) and Liver Cancer, Cancer of the Gastroesophageal (GE) Junction and Antacids, and Colon Cancer and Diet
Dr. Lenz (USC Norris Cancer Center) discusses colorectal highlights, the CMET pathway, cancer of the “ge” junction and diet.
Benjamin P. Levy, MD: The Challenges of Tissue for Lung Cancer Patients
Dr. Levy (Beth Israel Hospital, New York) discusses the challenges of tissue collection for lung cancer patients.
Joanne Mortimer, MD: Breast Cancer Update ASCO 2012 and Imaging of HER-2 Positive Metastatic Breast Cancer Using PET Technology
Dr. Mortimer (City of Hope Cancer Center) discusses breast cancer updates as well as an exciting City of Hope study involving functional imaging of HER2-positive metastatic breast cancer using 64Cu DOTA-trastuzumab positron emission tomography (PET).
Supriya G. Mohile, MD, MS: Older Patients and Cancer Treatment
Dr. Mohile (University of Rochester) discusses the impact of cancer on older patients.
Beverly Moy, MD, MPH: Core Elements of Patient Protection and Affordable Care Act (PPACA)
Dr. Moy is the Clinical Director of the Breast Oncology Program and a medical oncologist at the Massachusetts General Hospital.
David I. Quinn, MD: What’s New in Bladder Cancer Advances?, Bladder Cancer 101 and Prostate Cancer Update ASCO 2012
Dr. Quinn (USC Norris Cancer Center) brings us bladder and prostate cancer updates.
Sandeep K. Reddy, MD: Molecular Profiling and Target Now
Dr. Reddy (UCLA) discusses molecular profiling and the Target Now system.
Raul C. Ribeiro, MD: Advances in Pediatric Cancer and The St. Jude Difference
Dr. Ribeiro (St. Jude) talks about advances in pediatric cancer at St. Jude Children’s Research Hospital as well as its unique history.
Elizabeth S. Rodriguez, DNP, RN, OCN: How Communications Technology is Changing Patient Care
Elizabeth Rodriguez gives us an overview of the patient portals at Memorial Sloan-Kettering and and how communications technology is changing patient care.
Mace L. Rothenberg, MD: The Challenges of Drug Development in the Pharmaceutical Industry and Getting a Drug to Market
Dr. Rothenberg (Pfizer) gives us an educational overview of drug development from the pharmaceutical industry perspective and takes us through the process of getting a drug to market.
Gilles A. Salles, MD, PhD: Controversies in Indolent Lymphoma
Dr. Salles (Université de Lyon, France) discusses indolent lymphoma research.
Lidia Schapira, MD: Talking in Sync with Patients Across Cultural Barriers; Part 1 of 2 and Part 2 of 2
Dr. Schapira (Harvard Medical School / Massachusetts General Hospital) discusses clinician-patient communication, improvements in clinical decision making, and eliminating mistrust as ways of improving disparities in cancer care.
Daniel Von Hoff, MD, FACP: A Pancreatic Cancer Poster Session
Dr. Von Hoff introduces us to his poster session. His poster focuses on finding new targets for pancreatic cancer patients to try to treat the cancer more effectively.
The Group Room at the American Society of Clinical Oncology (ASCO) Annual Meeting 2012 was made possible, in part, by: